2019
|
Invention
|
Antibodies for the prevention or the treatment of bleeding episodes. The invention relates to an ... |
2018
|
Invention
|
Methods and pharmaceutical compositions for the treatment of acute exacerbations of chronic obstr... |
|
Invention
|
Hepatitis e virus orf2 capsid polypeptides and uses thereof. Hepatitis E virus (HEV) is responsib... |
2016
|
Invention
|
Methods of prognosis and treatment of patients suffering from acute myeloid leukemia. The present... |
2015
|
Invention
|
Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influ... |
|
Invention
|
Treatment of acute exacerbations of chronic obstructive pulmonary disease by antagonism of the il... |
|
Invention
|
Compounds targeting the bfl-1 anti-apoptotic protein and uses thereof for the treatment of cancer... |
|
Invention
|
Pharmaceutical compositions comprising an at2r agonist for treating pain. The present invention r... |
2014
|
Invention
|
Methods for determining human sperm quality. The present invention relates generally to the field... |
|
Invention
|
Methods and pharmaceutical compositions for the treatment of bacterial infections. The present in... |
|
Invention
|
Anastomotic device for joining lumens or viscera to each other. The invention relates to an anast... |
2013
|
Invention
|
Spiroisoxazoline compounds having an activity potentiating the activity of an antibiotic. The pre... |
|
Invention
|
Mycobacteria . The present invention concerns a compound of general formula (I):
in which n=0 o... |
|
Invention
|
Saturated nitrogen and n-acylated heterocycles potentiating the activity of an active antibiotic ... |
|
Invention
|
Antibodies specific to tau phosphorylated at serine 422 and uses for the treatment and diagnosis ... |
|
Invention
|
Compounds for use in the treatment of mycobacterial infections. The present invention concerns co... |
|
Invention
|
Methods and kits for predicting the survival time of post acute myocardial infarction patients. T... |
|
Invention
|
28 kda gst proteins from schistosoma for the use thereof in the treatment of inflammatory autoimm... |
2012
|
Invention
|
Fluoralkylcarbonyl-oxadiazoles. The present invention relates to compounds of Formula (I)
where... |
|
Invention
|
1, 2, 4 - oxadiazole derivatives as ethr inhibitors for use in the treatment tuberculosis. The pr... |
|
Invention
|
Anastomotic device and method for manufacturing such a device. The present invention relates to a... |
|
Invention
|
Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in... |
2011
|
Invention
|
Method for obtaining differentiated articular chondrocytes in vitro or ex vivo, and uses of same.... |
2009
|
Invention
|
Implant for treating a genital prolapse, and associated treatment method. The invention relates t... |
|
Invention
|
Method for detecting the differential expression of a set of molecular markers associated with pa... |
|
Invention
|
Impervious vascular prosthesis and method for preparing said prosthesis. The invention relates to... |
2008
|
Invention
|
Fto gene polymorphisms associated to obesity and/or type ii diabetes.
The present invention prov... |
|
Invention
|
Fto gene polymorphisms associated to obesity and/or type ii diabetes. The present invention provi... |
2006
|
Invention
|
Enpp1 (pc-1) gene haplotype associated with the risk of obesity and type 2 diabetes and their app... |